Department of Health and Human Services December 2021 – Federal Register Recent Federal Regulation Documents

Results 251 - 261 of 261
Agency Information Collection Activities; Proposed Collection; Comment Request; Food Labeling: Notification Procedures for Statements on Dietary Supplements
Document Number: 2021-26172
Type: Notice
Date: 2021-12-02
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA, Agency, or we) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the information collection provisions of the regulation requiring the manufacturer, packer, or distributor of a dietary supplement to notify us that it is marketing a dietary supplement product that bears on its label or in its labeling a statement provided for in the Federal Food, Drug, and Cosmetic Act (FD&C Act).
Aurolife Pharma LLC, et al.; Withdrawal of Approval of Five Abbreviated New Drug Applications
Document Number: 2021-26170
Type: Notice
Date: 2021-12-02
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or Agency) is withdrawing approval of five abbreviated new drug applications (ANDAs) from multiple applicants. The applicants notified the Agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.
Notice of Meeting; National Advisory Committee on the Sex Trafficking of Children and Youth in the United States
Document Number: 2021-26167
Type: Notice
Date: 2021-12-02
Agency: Department of Health and Human Services, Administration for Children and Families
Notice is hereby given, pursuant to the provisions of the Federal Advisory Committee Act (FACA) and the Preventing Sex Trafficking and Strengthening Families Act, that a meeting of the National Advisory Committee on the Sex Trafficking of Children and Youth in the United States (Committee) will be held on December 9 and 10, 2021. The purpose of the meeting is for the Committee to review state self-assessment survey responses and finalize their January 2022 report. The members of the Committee request comments from the public to inform their ongoing work and January 2022 report. Please submit your comments to NAC@nhttac.org with the subject ``NAC Comments,'' as soon as possible and before December 6, 2021.
Notice of Hearing: Reconsideration of Disapproval South Carolina Medicaid State Plan Amendment (SPA) 19-0004-A
Document Number: 2021-26136
Type: Notice
Date: 2021-12-01
Agency: Centers for Medicare & Medicaid Services, Department of Health and Human Services
This notice announces an administrative hearing to be held on January 12, 2022, at the Department of Health and Human Services, Division of Medicaid Field Operations, South, Centers for Medicare & Medicaid Services, Division of Medicaid and Children's Health Operations, 61 Forsyth St., Suite 4T20, Atlanta, Georgia 30303-8909 to reconsider CMS' decision to disapprove South Carolina's Medicaid SPA 19-0004-A.
National Institute of Allergy and Infectious Diseases; Notice of Meetings
Document Number: 2021-26134
Type: Notice
Date: 2021-12-01
Agency: Department of Health and Human Services, National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Meeting
Document Number: 2021-26121
Type: Notice
Date: 2021-12-01
Agency: Department of Health and Human Services, National Institutes of Health
Advisory Committee; Patient Engagement Advisory Committee; Renewal
Document Number: 2021-26118
Type: Notice
Date: 2021-12-01
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing the renewal of the Patient Engagement Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the Patient Engagement Advisory Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect until the October 6, 2023, expiration date.
National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
Document Number: 2021-26117
Type: Notice
Date: 2021-12-01
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Document Number: 2021-26115
Type: Notice
Date: 2021-12-01
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of Meeting
Document Number: 2021-26114
Type: Notice
Date: 2021-12-01
Agency: Department of Health and Human Services, National Institutes of Health
Privacy Act of 1974; System of Records
Document Number: 2021-26090
Type: Notice
Date: 2021-12-01
Agency: Department of Health and Human Services
In accordance with the requirements of the Privacy Act of 1974, as amended, the U.S. Department of Health and Human Services (HHS) is establishing a new departmentwide system of records, 09-90- 2103, Accommodation Records About HHS Civilian Employees, Contractors and Visitors.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.